Michael Theisen

Københavns Universitet

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Susheel K Singh

Københavns Universitet

DENMARK

View details

Thomas Alexander Gerds

Københavns Universitet

DENMARK

View details

Morten Hanefeld Dziegiel

Københavns Universitet

DENMARK

View details

Eizo Takashima

Associate professor

Ehime University

JAPAN

View details

Mohammad Naghizadeh

Københavns Universitet

DENMARK

View details

Pierre BUFFET

Professor

Paris university

FRANCE

View details

Nadia D Domingo

Research Teaching Specialist

Rutgers, The State Univ. of NJ

UNITED STATES

View details

Ikhlaq Kana

Københavns Universitet

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Theisen

Research Interests

Explore related searches

Contact this professor

Articles (19)

Magnitude and durability of ProC6C-AlOH/Matrix-Mtm vaccine-induced malaria transmission-blocking antibodies in Burkinabe adults from a Phase 1 randomized trial

Novel, fully human, anti-PfCSP antibodies with potent antimalarial activity using a phage display based strategy

Wider antibody breadth against multiple Plasmodium falciparum antigens is associated with reduced risk of malaria in a transmission hotspot in southern Ghana

IgG and IgM responses to the Plasmodium falciparum asexual stage antigens reflect respectively protection against malaria during pregnancy and infanthood.

Clinical formulation development of Plasmodium falciparum malaria vaccine candidates based on Pfs48/45, Pfs230, and PfCSP

A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults

ProC6C, a novel multi-stage malaria vaccine, elicits functional antibodies against the minor and central repeats of the Circumsporozoite Protein in human adults

A Pfs48/45-based vaccine to block Plasmodium falciparum transmission

Plasmodium falciparum AMA1 and CSP antigen diversity in parasite isolates from southern Ghana

B-Cell epitope mapping of the Plasmodium falciparum malaria vaccine candidate GMZ2.6c in a naturally exposed population of the Brazilian Amazon

High opsonic phagocytosis activity and growth inhibition of merozoites are associated with RON4 antibody levels and protect against febrile malaria in Ghanaian children

Human blood neutrophils generate ROS through FcγR-signaling to mediate protection against febrile P. falciparum malaria

Susceptibility to malaria in fulani, Bariba, Otamari and gando individuals living in sympatry in Benin

40 Years of Pfs48/45 Research as a Transmission-Blocking Vaccine Target of Plasmodium falciparum Malaria

Anti-gametocyte antigen humoral immunity and gametocytemia during treatment of uncomplicated falciparum malaria

Association of Immunoglobulin G3 Hinge Region Length Polymorphism With Cerebral Malaria in Ghanaian Children

Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial

Fcγ receptor IIIB NA1/NA2/SH polymorphisms are associated with malaria susceptibility and antibody levels to P. falciparum merozoite antigens in Beninese children

GMZ2 vaccine-induced antibody responses, naturally acquired immunity and the incidence of malaria in Burkinabe children

Collaborators (8)

Susheel K Singh

Thomas Alexander Gerds

Morten Hanefeld Dziegiel

Eizo Takashima

Mohammad Naghizadeh

Pierre BUFFET

Nadia D Domingo

Ikhlaq Kana

Make your next move.